UNSPSC 85731865: Removal of stimulator lead from bladder, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to removal of stimulator lead from bladder, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0TPB4MZ

UNSPSC 85731865 Removal of stimulator lead from bladder, percutaneous endoscopic approach is a Commodity code that shows minimal alignment between its nominal scope and current state and local procurement activity. The recent opportunities tagged under this code do not involve bladder stimulator lead removal or any percutaneous endoscopic procedures; instead, they span occupational medical surveillance, pharmacy benefit management, independent medical evaluations for public safety retirement determinations, surgical benefit carve-out networks, temporary health professional staffing, and emergency medical services for youth in custody. State and local buyers posting under this code include county health systems, county human resources and benefits divisions, state transportation agencies, county probation departments, and city pension and retirement offices.

Geographic activity appears concentrated in California (Santa Clara County Health System, City of Long Beach), Florida (Collier County), Texas (Harris County), Arizona (City of Phoenix), and Washington State (Washington State Department of Transportation). Representative recent opportunities include the Washington State Department of Transportation's occupational medical surveillance RFP (due October 9, 2026) seeking baseline and periodic medical examinations for ferry workers across 14 Washington locations, and the City of Phoenix Retirement Office's RFP for independent medical evaluation services (due October 16, 2026) supporting disability benefit determinations for approximately 75 annual applications at $750,000 over five years. The code's tagging appears to reflect a data-classification mismatch rather than genuine procurement of bladder stimulator devices or procedures; businesses evaluating this code should verify actual opportunities through direct source review rather than relying on the code's nominal surgical scope.